Drug Type ASO |
Synonyms THOR 213, THOR213 |
Target |
Action inhibitors |
Mechanism CD74 inhibitors(HLA-DR antigens-associated invariant chain inhibitors), MIF inhibitors(Macrophage migration inhibitory factor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cachexia | Preclinical | South Korea | 30 Sep 2024 |





